Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Driven by 7 papers. Top paper: “Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 study”.
Geraldine O’Sullivan Coyne, Pamela L. Wolters, Staci Martin, Said Farschtschi, Ignacio Blanco +38 more
Seiji Kondo, Shunsuke Funakoshi, Makiko Abe, Atsushi Satoh, Miki Kawazoe +15 more
Shunsuke Hamada, Tomohisa Sakai, Koki Shimizu, Masahiro Yoshida, Yoshihiro Nishida +1 more
Hiroyuki Kawashima, Akira Kawai, Masahiro Yoshida, Yoshihiro Nishida, Koki Shimizu
Caitlin M. Howard, Emma Pendergraft, Kenneth R. Brittian, Timothy N. Audam, Exile W. Lukudu +8 more
Christopher D. Steele, Katherine Piculell, Alyaa Al‐Ibraheemi, Vanessa Eulo, Marilyn M. Bui +26 more
Shunsuke Hamada, Hiroshi Koike, Koki Shimizu, Masahiro Yoshida, Yoshihiro Nishida +1 more